We are live on
!
Find out more
EVM
Eaton Vance Management Portfolio holdings
AUM
$67.5B
1-Year Est. Return
11.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
-11.44%
3 Year Est. Return
+49.6%
5 Year Est. Return
+94.25%
10 Year Est. Return
–
AUM
$35.5B
AUM Growth
+$758M
(+2.2%)
Cap. Flow
-$173M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
1,034
New
63
Increased
342
Reduced
364
Closed
32
Top Buys
| 1 |
Altria Group
MO
|
+$159M |
| 2 |
Zoetis
ZTS
|
+$149M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
C.H. Robinson
CHRW
|
+$85.6M |
| 5 |
Estee Lauder
EL
|
+$78.5M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
+$301M |
| 2 |
RTX Corp
RTX
|
+$224M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$196M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$116M |
| 5 |
Rockwell Automation
ROK
|
+$114M |
Sector Composition
| 1 | Financials | 17.73% |
| 2 | Healthcare | 15.96% |
| 3 | Technology | 13.07% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$63.6B
| $308M | 0.87% |
6,068,189
-623,327
| -9% | -$32M |
|
27
Goldman Sachs
GS
$332B
| $304M | 0.86% |
1,269,063
-297,052
| -19% | -$60.3M |
|
28
Occidental Petroleum
OXY
$54.5B
| $295M | 0.83% |
4,142,699
-523,359
| -11% | -$37.2M |
|
29
PepsiCo
PEP
$189B
| $294M | 0.83% |
2,813,657
+190,057
| +7% | +$19.9M |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $287M | 0.81% |
1,367,214
-312,586
| -19% | -$64.8M |
|
|
31
RTX Corp
RTX
$267B
| $279M | 0.79% |
4,045,025
-3,384,284
| -46% | -$224M |
|
32
US Bancorp
USB
$98.2B
| $278M | 0.78% |
5,418,489
-1,674,160
| -24% | -$79.6M |
|
33
Berkshire Hathaway Class B
BRK.B
$1.07T
| $271M | 0.76% |
1,665,224
+126,121
| +8% | +$19.4M |
|
34
EOG Resources
EOG
$73.9B
| $268M | 0.76% |
2,653,498
-274,266
| -9% | -$26.7M |
|
35
Union Pacific
UNP
$172B
| $261M | 0.74% |
2,520,372
+360,454
| +17% | +$35.4M |
|
|
APC
36
DELISTED
Anadarko Petroleum
APC
| $256M | 0.72% |
3,672,001
+1,170,253
| +47% | +$76.1M |
|
|
37
Zoetis
ZTS
$31.2B
| $239M | 0.67% |
4,470,562
+2,939,619
| +192% | +$149M |
|
38
Starbucks
SBUX
$122B
| $233M | 0.66% |
4,189,207
+90,104
| +2% | +$4.99M |
|
39
Qualcomm
QCOM
$191B
| $224M | 0.63% |
3,439,781
+721,147
| +27% | +$48.4M |
|
|
40
C.H. Robinson
CHRW
$23.3B
| $219M | 0.62% |
2,993,317
+1,183,126
| +65% | +$85.6M |
|
41
Costco
COST
$411B
| $218M | 0.61% |
1,359,654
+173,859
| +15% | +$26.5M |
|
42
Bristol-Myers Squibb
BMY
$119B
| $215M | 0.61% |
3,676,379
-106,157
| -3% | -$5.8M |
|
43
Amgen
AMGN
$193B
| $215M | 0.6% |
1,468,557
-14,639
| -1% | -$2.2M |
|
44
Procter & Gamble
PG
$342B
| $212M | 0.6% |
2,521,791
+523,415
| +26% | +$44.6M |
|
45
Halliburton
HAL
$29.6B
| $210M | 0.59% |
3,882,389
+911,841
| +31% | +$45.5M |
|
46
Equity Residential
EQR
$25.9B
| $206M | 0.58% |
3,197,741
-295,086
| -8% | -$18.1M |
|
47
Gilead Sciences
GILD
$162B
| $202M | 0.57% |
2,822,760
-1,048,156
| -27% | -$77.9M |
|
48
Biogen
BIIB
$28.7B
| $199M | 0.56% |
700,891
+205,238
| +41% | +$60.8M |
|
49
Oracle
ORCL
$372B
| $196M | 0.55% |
5,099,453
-219,485
| -4% | -$8.58M |
|
50
Medtronic
MDT
$103B
| $193M | 0.54% |
2,704,931
-195,758
| -7% | -$15.4M |
|
Similar funds
ACM
AII
MFRM
MA
5L
JG
RC
W